Histidine-rich glycoprotein as a prognostic biomarker for sepsis

AbstractVarious biomarkers have been proposed for sepsis; however, only a few become the standard. We previously reported that plasma histidine-rich glycoprotein (HRG) levels decreased in septic mice, and supplemental infusion of HRG improved survival in mice model of sepsis. Moreover, our previous clinical study demonstrated that HRG levels in septic patients were lower than those in noninfective systemic inflammatory response syndrome patients, and it could be a biomarker for sepsis. In this study, we focused on septic patients and assessed the differences in HRG levels between the non-survivors and survivors. We studied ICU patients newly diagnosed with sepsis. Blood samples were collected within 24 h of ICU admission, and HRG levels were determined using an enzyme-linked immunosorbent assay. Ninety-nine septic patients from 11 institutes in Japan were included. HRG levels were significantly lower in non-survivors (n = 16) than in survivors (n = 83) (median, 15.1 [interquartile ranges, 12.7–16.6] vs. 30.6 [22.1–39.6] µg/ml; p < 0.01). Survival analysis revealed that HRG levels were associated with mortality (hazard ratio 0.79, p < 0.01), and the Harrell C-index (predictive power) for HRG was 0.90. These results suggested that HRG could be a novel prognostic biomarker for sepsis.

Download Full-text

SARS-CoV-2 RNAemia and proteomic biomarker trajectory inform prognostication in COVID-19 patients admitted to intensive care

10.21203/rs.3.rs-101592/v1 ◽

2020 ◽

Author(s):

Manuel Mayr ◽

Clemens Gutmann ◽

Kaloyan Takov ◽

Sean Burnap ◽

Bhawana Singh ◽

...

Keyword(s):

Intensive Care ◽

Neutralizing Antibody ◽

Icu Mortality ◽

Icu Patients ◽

Mortality Hazard ◽

Interaction Partners ◽

Galectin 3 ◽

The Complement System ◽

Mortality Hazard Ratio ◽

Age And Sex

Abstract Prognostic characteristics inform risk stratification in intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19). We obtained blood samples (n = 474) from hospitalized COVID-19 patients (n = 123), non-COVID-19 ICU sepsis patients (n = 25) and healthy controls (n = 30). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA was detected in plasma or serum (RNAemia) of COVID-19 ICU patients when neutralizing antibody response was low. RNAemia was associated with higher 28-day ICU mortality (hazard ratio [HR], 1.84 [95% CI, 1.22–2.77] adjusted for age and sex). In longitudinal comparisons, COVID-19 ICU patients had a distinct proteomic trajectory associated with RNAemia and mortality. Among COVID-19-enriched proteins, galectin-3 binding protein (LGALS3BP) and proteins of the complement system were identified as interaction partners of SARS-CoV-2 spike glycoprotein. Finally, machine learning identified ‘Age, RNAemia’ and ‘Age, pentraxin-3 (PTX3)’ as the best binary signatures associated with 28-day ICU mortality.

Download Full-text

Quantitative ELISA for SERPINA4/kallistatin

BioTechniques ◽

10.2144/btn-2018-0194 ◽

2021 ◽

Author(s):

Kurpad Nagaraj Shashidhar ◽

Venkata Lakshmaiah ◽

Chandrappa Muninarayana ◽

Krishna Sumanth Nallagangula

Keyword(s):

Liver Diseases ◽

Blood Circulation ◽

Prognostic Biomarker ◽

Research Centre ◽

Enzyme Linked Immunosorbent Assay ◽

Chronic Liver Diseases ◽

Blood Samples ◽

Multifunctional Protein ◽

Assay Precision ◽

Monospecific Antibodies

Background: SERPINA4/kallistatin is a multifunctional protein expressed from the liver; its concentration in blood circulation reflects the degree of liver dysfunction and may serve as a diagnostic/prognostic biomarker for chronic liver diseases (CLD). Materials & methods: Antibodies specific for SERPINA4/kallistatin were used for the development of an enzyme-linked immunosorbent assay (ELISA). For correlative studies, blood samples from patients with cirrhotic liver and healthy patients were collected from R.L. Jalappa Hospital & Research Centre, Kolar. Results: Interference of other SERPINs was ruled out using western blot analysis. Quantitative ELISA was developed using monospecific antibodies as capture antibodies. Conclusion: The accuracy of the developed ELISA was determined by inter- and intra-assay precision. Linearity was defined using a spiked sample with serial dilutions. Reduced levels of SERPINA4/kallistatin were observed in patients with CLD compared with healthy controls.

Download Full-text

The short-term prognostic value of serum platelet to hemoglobin in patients with type A acute aortic dissection

Perfusion ◽

10.1177/0267659120982226 ◽

2020 ◽

pp. 026765912098222

Author(s):

Yu Wang ◽

Tengfei Qiao ◽

Jun Zhou

Keyword(s):

Aortic Dissection ◽

Hospital Mortality ◽

Acute Aortic Dissection ◽

Independent Predictor ◽

Type A ◽

Short Term ◽

Survivor Group ◽

Mortality Hazard ◽

Mortality Hazard Ratio ◽

The Ideal

Purpose: Type A acute aortic dissection (AAD) is an uncommon catastrophic cardiovascular disease with high pre-hospital mortality rate without timely and effectively treated. The aim of this study was to assess the value of serum platelet to hemoglobin (PHR) in predicting in-hospital mortality in type A AAD patients. Methods: A total of 183 type A AAD patients were included in this retrospective investigation from January 2017 to December 2019. Admission blood routine parameters were gathered and PHR was computed. The outcome was all-cause in-hospital mortality within 30 days. Results The average levels of serum PHR were significant higher in survivor group than those in non-survivor group (1.14 ± 0.57 vs 0.87 ± 0.47, p = 0.006) and serum PHR was an independent factor associated with in-hospital mortality (hazard ratio (HR): 2.831; 95% confidence interval (CI): 1.108–7.231; p = 0.030). ROC noted that 0.8723 was chosen as the ideal cutoff value with a sensitivity of 64.3% and specificity of 72.5%. In addition, the area under the ROC curve (AUC) was 0.693 (95% CI 0.599–0.787, p < 0.001). Conclusion: Admission serum PHR can be used as an independent predictor of in-hospital mortality in patients with type A AAD.

Download Full-text

Increased Serum WISP1 Levels are Associated with Lower Extremity Atherosclerotic Disease in Patients with type 2 Diabetes Mellitus

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/a-1474-8220 ◽

2021 ◽

Author(s):

Yangyang Cheng ◽

Xiaohui Du ◽

Bilin Zhang ◽

Junxia Zhang

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lower Extremity ◽

Interleukin 6 ◽

Atherosclerotic Disease ◽

Enzyme Linked Immunosorbent Assay ◽

Diabetic Patients ◽

Newly Diagnosed

Abstract Background Serum wnt1-induced signaling pathway protein 1 (WISP1) levels are increased with obesity, which is a common complication associated with lower extremity atherosclerotic disease (LEAD). However, to date, the relationship between elevated WISP1 levels and the incidence of lower extremity atherosclerotic disease (LEAD) in type 2 diabetes mellitus (T2DM) remains unclear. Methods 174 newly diagnosed type 2 diabetic patients were enrolled in our study. Patients were divided into two groups, LEAD group (n=100) and control group (n=74). Anthropometric parameters, blood pressure and some biochemical parameters were obtained. Body composition was detected by bioelectrical impedance analysis (BIA). Levels of serum insulin were determined by radioimmunoassay. Serum WISP1 and interleukin 6 (IL-6) levels were determined using an enzyme-linked immunosorbent assay. Results It was shown that serum WISP1 levels in diabetic patients with LEAD were higher than those without LEAD (P<0.001). Serum WISP1 levels were positively related with waist circumference (r=0.237, P=0.003), waist-hip ratio (r=0.22, P=0.006), visceral fat area (r=0.354, P<0.001), serum creatinine (r=0.192, P=0.012), interleukin 6 (r=0.182, P=0.032), c-reactive protein (r=0.681, P<0.001), triglycerides (r=0.119, P<0.001), fasting glucose (r=0.196, P=0.011), glycated hemoglobin (r=0.284, P<0.001), and HOMA-IR (r=0.285, P<0.026). Compared with the lowest tertile, the odds ratio of the middle tertile for LEAD incidence was 3.27 (95% CI, 1.24–8.64) and 4.46 (95% CI, 1.62–12.29) for the highest tertile after adjusting confounding factors. Conclusion The results suggest that increased serum WISP1 levels independently contribute to the incidence of LEAD in patients with newly diagnosed T2DM.

Download Full-text

Chronic kidney disease stage stratifies short- and long-term outcomes after aortic root replacement

Interactive Cardiovascular and Thoracic Surgery ◽

10.1093/icvts/ivaa320 ◽

2020 ◽

Author(s):

Tsuyoshi Yamabe ◽

Yanling Zhao ◽

Paul A Kurlansky ◽

Suzuka Nitta ◽

Saveliy Kelebeyev ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Confidence Interval ◽

Aortic Root Replacement ◽

Mortality Hazard ◽

Group 3 ◽

Group 2 ◽

Mortality Hazard Ratio ◽

Group 1

Abstract OBJECTIVES Chronic kidney disease (CKD) is prevalent in patients undergoing cardiovascular surgery, and it negatively impacts procedural outcomes; however, its influence on the outcomes of aortic surgery has not been well studied. This study aims to elucidate the importance of CKD on the outcomes of aortic root replacement (ARR). METHODS Patients who underwent ARR between 2005 and 2019 were retrospectively reviewed (n = 882). Patients were divided into 3 groups based on the Kidney Disease: Improving Global Outcomes criteria: Group 1 [estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73 m2, n = 421); Group 2 (eGFR = 30–59 ml/min/1.73 m2, n = 424); and Group 3 (eGFR < 30 ml/min/1.73 m2, n = 37). To reduce potential confounding, a propensity score matching was also performed between Group 1 and the combined group of Group 2 and Group 3. The primary end point was 10-year survival. Secondary end points were in-hospital mortality and perioperative morbidity. RESULTS Severe CKD patients presented with more advanced overall chronic and acute illnesses. Kaplan–Meier analysis showed a significant correlation between CKD stage and 10-year survival (log-rank P < 0.001). The number of events for Group 1 was 15, Group 2 was 49 and Group 3 was 11 in 10 years. Group 3 had significantly higher in-hospital mortality (13.5% vs 3.5% in Group 2 vs 0.7% in Group 1, P < 0.001) and stroke (8.1% vs 7.1% vs 1.2%, P < 0.001) as well as introduction to new dialysis (27.0% vs 5.4% vs 1.7%, P < 0.001). eGFR was shown to be an independent predictor of mortality (hazard ratio, 0.98; 95% confidence interval, 0.96–0.99). Comparison between propensity matched groups showed similar postoperative outcomes, and eGFR was still identified as a predictor of mortality (hazard ratio, 0.97; 95% confidence interval, 0.95–0.99). CONCLUSIONS Higher stage in CKD negatively impacts the long-term survival in patients who are undergoing ARR.

Download Full-text

Insulin Resistance as a Predictor of Cardiovascular Disease in Patients on peritoneal dialysis

Peritoneal Dialysis International ◽

10.3747/pdi.2012.00037 ◽

2013 ◽

Vol 33 (4) ◽

pp. 411-418 ◽

Cited By ~ 21

Author(s):

Yun Li ◽

Lihua Zhang ◽

Yong Gu ◽

Chuanming Hao ◽

Tongying Zhu

Keyword(s):

Insulin Resistance ◽

Peritoneal Dialysis ◽

Independent Predictor ◽

Hazard Ratio ◽

Diabetic Patients ◽

Model Assessment ◽

Mortality Hazard ◽

Cv Disease ◽

The Impact ◽

Mortality Hazard Ratio

BackgroundInsulin resistance is associated with multiple risk factors for cardiovascular (CV) disease in the general population. Patients on peritoneal dialysis (PD) are more likely to develop insulin resistance. However, no evaluation of the impact of insulin resistance on CV disease morbidity or mortality in patients on PD has been performed.MethodsOur prospective cohort study included all non-diabetic patients on PD at our center ( n = 66). Insulin resistance was evaluated at baseline by the homeostasis model assessment method (HOMA-IR) using fasting glucose and insulin levels. The cohort was followed for up to 58 months (median: 41.3 months; interquartile range: 34.3 months). A multivariate Cox model was used to analyze the impact of insulin resistance on CV disease mortality.ResultsFourteen CV events occurred in the higher HOMA-IR group [IR-H (HOMA-IR values in the range 2.85 – 19.5), n = 33], but only one event occurred in the lower HOMA-IR group (IR-L (HOMA-IR values in the range 0.83 – 2.71), n = 33) during the follow-up period. Level of HOMA-IR was a significant predictor of CV events [risk ratio: 17.7; 95% confidence interval (CI): 2.10 to 149.5; p = 0.008]. In the IR-H group, 10 patients died (8 CV events), but in the IR-L group, only 4 patients died (1 CV event). Patients in the IR-H group experienced significantly higher CV mortality (hazard ratio: 9.02; 95% CI: 1.13 to 72.2; p = 0.04). Even after adjustments for age, systolic blood pressure, body mass index, C-reactive protein, triglycerides, resistin, and leptin, HOMA-IR remained an independent predictor of CV mortality (hazard ratio: 14.8; 95% CI: 1.22 to 179.1; p = 0.03).ConclusionsInsulin resistance assessed using HOMA-IR was an independent predictor of CV morbidity and mortality in a cohort of nondiabetic patients on PD. Insulin resistance is a modifiable risk factor; the reduction of insulin resistance may reduce CV risk and improve survival in this group of patients.

Download Full-text

Soluble P-selectin and correlation with Prothrombin Fragment 1 + 2 in myeloid malignancies in Cipto Mangunkusumo general hospital

Thrombosis Journal ◽

10.1186/s12959-021-00307-5 ◽

2021 ◽

Vol 19 (1) ◽

Author(s):

Lugyanti Sukrisman

Keyword(s):

Acute Myeloid Leukemia ◽

Chronic Myeloid Leukemia ◽

Myeloid Leukemia ◽

Leukocyte Count ◽

Endothelial Activation ◽

Enzyme Linked Immunosorbent Assay ◽

Newly Diagnosed ◽

Prothrombin Fragment ◽

Soluble P ◽

Acute Myeloid

Abstract Background Myeloid cells express microparticles that could increase the expression of adhesion molecules including P-selectin. We aimed to evaluate the level of soluble P-selectin (sP-selectin) and prothrombin fragment 1 + 2 (F1 + 2), and to determine correlation of sP-selectin with leukocyte count and F1 + 2 levels in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients. Methods Patients with newly diagnosed AML (n = 25), CML (n = 13), and controls (n = 17) were recruited in this study. The diagnosis of AML and CML is based on 2001 WHO and/or FAB criteria. Levels of sP-selectin and F1 + 2 were determined using enzyme-linked immunosorbent assay kits (Behring ELISA Processor-III® and Behring Enzygnost F1 + 2). Results sP-selectin was significantly elevated in CML patients compared to AML patients (p = 0.001). Levels of F1 + 2 in AML and CML patients were significantly increased in comparison to controls (p < 0.001 and p = 0.043). Levels of sP-selectin were significantly correlated to leukocyte count (r = 0.437; p = 0.029) and F1 + 2 (r = 0.436; p = 0.029) in AML patients. Conclusions AML and CML patients had an increased tendency to thrombosis. While CML patients had higher platelet and/or endothelial activation, hypercoagulable state are more pronounced in AML patients.

Download Full-text

Epidemiological survey on gastro-intestinal and blood-borne helminths of dogs in north-east Gabon : research communication

Onderstepoort Journal of Veterinary Research ◽

10.4102/ojvr.v75i4.112 ◽

2008 ◽

Vol 75 (4) ◽

Cited By ~ 12

Author(s):

B. Davoust ◽

T. Normand ◽

O. Bourry ◽

H. Dang ◽

E. Leroy ◽

...

Keyword(s):

Immunosorbent Assay ◽

Epidemiological Survey ◽

Enzyme Linked Immunosorbent Assay ◽

Helminth Parasites ◽

Intestinal Helminths ◽

Spirocerca Lupi ◽

Faecal Examination ◽

Blood Samples ◽

North East ◽

Trichuris Vulpis

A survey of helminth parasites was carried out on 198 dogs living in almost complete liberty in villages in the northeast of Gabon. Faeces and blood samples were collected and analysed. Dirofilariaimmitis antigen was detected in 13.6 % of dogs using the SNAP 3Dx® test, a commercially available enzyme-linked immunosorbent assay (ELISA). Faecal examination revealed that 91.4 % of dogs were infected by intestinal helminths. Ascarids were found in 58.5 % of the samples. Trichuris vulpis was observed in 49.5 % of cases, and Uncinaria spp. and Ancylostoma spp. in 34.8 %, Spirocerca lupi in 25.3 % and Capillaria spp. in 10.6 %. Cestode embryophores were found in 8.6 % of the samples.

Download Full-text

Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination

Epidemiology and Infection ◽

10.1017/s0950268811002184 ◽

2011 ◽

Vol 140 (9) ◽

pp. 1599-1606 ◽

Cited By ~ 16

Author(s):

E. BORRÀS ◽

L. URBIZTONDO ◽

J. COSTA ◽

J. BATALLA ◽

N. TORNER ◽

...

Keyword(s):

Immunosorbent Assay ◽

Maternal Antibodies ◽

Passive Immunity ◽

Enzyme Linked Immunosorbent Assay ◽

Igg Antibodies ◽

Blood Samples ◽

Measles Outbreak ◽

Measles Antibodies ◽

Measles Vaccination

SUMMARYPassive immunity against measles decreases during the first months of life. The objective of this study was to determine titres of measles antibodies in children aged 9–14 months and their mothers before vaccination, and the children's response to vaccination. Blood samples were collected by capillary puncture before and 28 days after vaccination. Samples were obtained between February and June 2007 during an ongoing measles outbreak. Titres of specific measles IgG antibodies were determined by enzyme-linked immunosorbent assay. Seroconversion was defined as the presence of antibodies after vaccination in subjects without antibodies before vaccination. Maternal antibodies were present in 37·7% of all 69 children included and in 45·1% of children aged 9 months. Of the 51 children in whom a second sample was obtained, 31 (60·8%) were seronegative before vaccination and 61·3% seroconverted. Interference of maternal antibodies was 30%. Advancing the first dose of measles vaccination from 15 to 12 months is a correct strategy, given the increase in the time of susceptibility of infants to measles.

Download Full-text

Asymptomatic Malaria Infection and Their Antibodies Against Malaria: A Study in Abra de Ilog, Occidental Mindoro, Philippines

American Journal of Clinical Pathology ◽

10.1093/ajcp/aqz121.028 ◽

2019 ◽

Vol 152 (Supplement_1) ◽

pp. S116-S116

Author(s):

Carlo Ledesma ◽

Ma Gina Sadang

Keyword(s):

Real Time ◽

Malaria Infection ◽

Malaria Parasite ◽

National Commission ◽

Enzyme Linked Immunosorbent Assay ◽

Asymptomatic Malaria ◽

Blood Samples ◽

Blood Smears ◽

Specific Igg

Abstract Human malaria, caused by four species of Plasmodium, namely P falciparum, P vivax, P malariae, and P ovale, remains a health problem of global concern, with one to two million deaths annually and risking about two billion people worldwide. Alternative ways of controlling the incidence of malaria through understanding the host’s immune response to monoinfection and the detection of the presence of asymptomatic malaria infection are the factors being addressed in this study. The determination of the possible existence of cross-antigenic stimulation is a matter of great significance for future research and development. The isolation of these antigenic structures may give the first step to the development of better vaccines that may protect the general population who are at risk of developing malaria. Prior to blood collection, a memorandum of agreement was signed between the researcher and the Iraya-Mangyan leaders of Abra de Ilog, Occidental Mindoro. A Certificate Precondition was issued by the National Commission of Indigenous Peoples, which was required by the Graduate School Ethics Review Committee. Determination of the presence of malaria parasite on blood samples of residents of two barangays in Abra de Ilog, Occidental Mindoro, was performed using two methods: microscopic examination of stained blood smears for the presence of malaria parasite and polymerase chain reaction. Blood smears were prepared and eventually stained using Giemsa and Dip Quick stains. The detection of 5 positive cases of malaria infection with ring/schizont stage among the 53 cases was a clear indication of positive asymptomatic cases. Nested PCR using Plasmodium spp.–specific primer as well as P falciparum–specific and P vivax–specific primers showed the absence of bands so that one of the recommendations in this study is the performance of real-time PRC using more sensitive primers. Levels of P falciparum and P vivax–specific immunoglobulin were measured using an enzyme-linked immunosorbent assay revealing a higher level of PF-specific IgG than PV-specific IgG. Whole blood samples were saved for future determinations such as real-time PCR, immunophenotypic analysis, and possible parasitic culture. Further similar studies may also be done by increasing the number of respondents as well as the areas of concern for a more extensive scope.

Download Full-text